Apps

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

IJR News — today's news from every side

Boliden Shares Fall as Banks Cut TargetsFinance — Jul 22, 2026Market watchers from BNP Paribas, Goldman Sachs, JP Morgan, and Barclays have issued downgrades or mixed guidance on Boliden, each referencing a composite rating framework that blends returns, profitability, financial reporting, and financial health. The reports present a range of target prices in kronor and reiterate different stance levels, reflecting a nuanced investor view on Boliden's risk and reward.

Analysts Trim Celldex Price Targets, Shares Fall — Jul 22, 2026Celldex Therapeutics faces a flurry of analyst revisions, with Cantor Fitzgerald and Canaccord Genuity trimming targets to 61 and 60 while maintaining overweight/buy ratings, and Morgan Stanley lowering its target to 40, reflecting mixed sentiment. Meanwhile, firms like Guggenheim and Wells Fargo have raised targets to around 100 and 54 respectively, indicating a broad range of views on the stock’s near-term prospects as it trades in the mid-30s.